BCYC vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BCYC

52.9
AI Score
VS
BCYC Wins

JBIO

32.5
AI Score

Investment Advisor Scores

BCYC

53score
Recommendation
STRONG BUY

JBIO

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric BCYC JBIO Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 190.2% 0.0% BCYC
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 52.9/100 32.5/100 BCYC
Profit Margin -169.8% 0.0% JBIO
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY BCYC

Relative Price Performance (Last 90 Days)

BCYC 1M: -0.6% · 3M: -10.5% JBIO 1M: +19.5% · 3M: -35.0%

Current Technical Phase

BCYC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.2%), weak momentum, RSI 43

RSI (14): 43.4 · Price: $3.49

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 57.9 · Price: $16.06

Fundamentals Snapshot

Metric BCYC JBIO
Market Cap — —
Forward P/E -1.6 -6.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.9% 0.0%
Gross Margin -1.0% —
Operating Margin -0.4% 0.0%
EPS -1.98 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, BCYC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.